It is possible that the missense mutations observed in our study population failed to affect NFE2L2 function and further analysis is needed to study the functional alteration of the mutated forms of NFE2L2 in the ESCC tissue samples. The gene discussed is NFE2L2; the disease is esophageal squamous cell carcinoma.